In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent Contractors
PharmExec
JULY 8, 2022
Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.
Let's personalize your content